Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Bero to Animals

This is a "connection" page, showing publications Lisa Bero has written about Animals.

 
Connection Strength
 
 
 
0.252
 
  1. Bero L, Anglemyer A, Vesterinen H, Krauth D. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis. Environ Int. 2016 Jul-Aug; 92-93:597-604.
    View in: PubMed
    Score: 0.030
  2. Anglemyer AT, Krauth D, Bero L. Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis. BMC Med Res Methodol. 2015 Mar 06; 15:12.
    View in: PubMed
    Score: 0.028
  3. Fox DM, Bero L. Systematic reviews: perhaps "the answer to policy makers' prayers"? Environ Health Perspect. 2014 Oct; 122(10):A262-3.
    View in: PubMed
    Score: 0.027
  4. Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environ Health Perspect. 2014 Mar; 122(3):A67.
    View in: PubMed
    Score: 0.026
  5. Krauth D, Anglemyer A, Philipps R, Bero L. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. PLoS Biol. 2014 Jan; 12(1):e1001770.
    View in: PubMed
    Score: 0.026
  6. Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect. 2013 Sep; 121(9):985-92.
    View in: PubMed
    Score: 0.025
  7. Sutton P, Woodruff TJ, Vogel S, Bero LA. Conrad and Becker's "10 Criteria" fall short of addressing conflicts of interest in chemical safety studies. Environ Health Perspect. 2011 Dec; 119(12):A506-7; author reply A508-9.
    View in: PubMed
    Score: 0.022
  8. Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Le Curieux F, Peters S, Shubat P, Sone H, White MC, Williamson J, Yakubovskaya M, Siemiatycki J, White PA, Guyton KZ, Schubauer-Berigan MK, Hall AL, Grosse Y, Bouvard V, Benbrahim-Tallaa L, El Ghissassi F, Lauby-Secretan B, Armstrong B, Saracci R, Zavadil J, Straif K, Wild CP. The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification. J Natl Cancer Inst. 2020 01 01; 112(1):30-37.
    View in: PubMed
    Score: 0.010
  9. Misakian AL, Bero LA. Publication bias and research on passive smoking: comparison of published and unpublished studies. JAMA. 1998 Jul 15; 280(3):250-3.
    View in: PubMed
    Score: 0.009
  10. Vandenberg LN, ?gerstrand M, Beronius A, Beausoleil C, Bergman ?, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, Jobling S, Kidd KA, Kortenkamp A, Macleod MR, Martin OV, Norinder U, Scheringer M, Thayer KA, Toppari J, Whaley P, Woodruff TJ, Rud?n C. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environ Health. 2016 07 14; 15(1):74.
    View in: PubMed
    Score: 0.008
  11. Johnson PI, Koustas E, Vesterinen HM, Sutton P, Atchley DS, Kim AN, Campbell M, Donald JM, Sen S, Bero L, Zeise L, Woodruff TJ. Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan. Environ Int. 2016 Jul-Aug; 92-93:716-28.
    View in: PubMed
    Score: 0.008
  12. Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, Macleod M, Tovey D, Tugwell P, White H, Sim I. Informatics: Make sense of health data. Nature. 2015 Nov 05; 527(7576):31-2.
    View in: PubMed
    Score: 0.007
  13. Bero LA, Roy S, Lee NM. Identification of endogenous opioid receptor components in rat brain using a monoclonal antibody. Mol Pharmacol. 1988 Nov; 34(5):614-20.
    View in: PubMed
    Score: 0.005
  14. Bero LA, Lurie SN, Kuhn CM. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat. Brain Res. 1987 Dec 15; 465(1-2):189-96.
    View in: PubMed
    Score: 0.004
  15. Bero LA, Kuhn CM. Role of serotonin in opiate-induced prolactin secretion and antinociception in the developing rat. J Pharmacol Exp Ther. 1987 Mar; 240(3):831-6.
    View in: PubMed
    Score: 0.004
  16. Bero LA, Kuhn CM. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion. J Pharmacol Exp Ther. 1987 Mar; 240(3):825-30.
    View in: PubMed
    Score: 0.004
  17. Bero LA, Kuhn CM. Catecholaminergic regulation of opiate-stimulated growth hormone secretion in the developing rat. J Pharmacol Exp Ther. 1986 Apr; 237(1):137-42.
    View in: PubMed
    Score: 0.004
  18. Kilts CD, Bero LA. Quantitative determination of 5-hydroxytryptophan in dissected brain regions by on-line trace enrichment HPLC with electrochemical detection. Life Sci. 1984 Jul 02; 35(1):87-95.
    View in: PubMed
    Score: 0.003
  19. Kuhn C, Bero L, Ignar D, Lurie S, Field E. Endocrine consequences of perinatal methadone exposure. NIDA Res Monogr. 1987; 78:72-94.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)